Physician profile
Rubin Bashir
NPI 1568653798
$7,535.93
in general payments reported to CMS, 2019-2025
20 companies · $2,396 in 2025
The $2,396 reported for 2025 was more than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,589 · 2020: $202 · 2021: $680 · 2022: $1,849 · 2023: $403 · 2024: $417 · 2025: $2,396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,716 · Food and Beverage: $1,499.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,716.06 |
| Food and Beverage | $1,499.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,443.36 | 2021-2024 | Everest Spinal System, Cascadia Interbody System |
| Alphatec Spine, INC | $1,875.79 | 2025 | Other - Miscellaneous |
| Medacta USA, INC. | $1,401.52 | 2019 | |
| Providence Medical Technology, INC. | $896.04 | 2020-2025 | |
| Si-Bone, INC. | $180.40 | 2019-2023 | |
| Amplify Surgical, INC. | $144.57 | 2021 | |
| Abbott Laboratories | $92.16 | 2023 | Proclaim |
| Abbvie INC. | $73.96 | 2025 | |
| Sk Life Science, INC. | $67.52 | 2025 | |
| Precision Spine, INC. | $64.93 | 2021 | |
| Zimmer Biomet Holdings, INC. | $60.27 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $58.84 | 2025 | |
| Horizon Therapeutics Plc | $40.68 | 2019-2020 | |
| Lundbeck LLC | $31.27 | 2025 | Rexulti |
| Ermi LLC | $21.13 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Pharmaceuticals Incorporated | $19.74 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $18.18 | 2025 | Austedo Xr |
| Intrinsic Therapeutics | $17.36 | 2023 | Barricaid Acd (Annular Closure Device) |
| Harmony Biosciences LLC | $16.78 | 2025 | |
| Merck Sharp & Dohme LLC | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rubin Bashir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.